Potentiation of angiotensin II action by corticosteroids in vascular tissue

Cardiovascular Research

Volumn 32, Issue 2, 1996, Pages 266-273

  Ullian, Michael E ^a   Walsh, Lyle G ^a   Morinelli, Thomas A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adrenocorticosteroids; Angiotensin II; Angiotensin receptor; Arterial tone; Chloroquine; Colchicine; Vascular smooth muscle

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CORTICOSTERONE; DEXAMETHASONE;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ADRENAL CORTEX HORMONES; ANGIOTENSIN II; ANIMALS; CHLOROQUINE; COLCHICINE; IMMUNOBLOTTING; METHIONINE; MUSCLE, SMOOTH, VASCULAR; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; UP-REGULATION; VASOCONSTRICTION;

EID: 0030222294     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00053-3     Document Type: Article

References (37)

1. [1] Berecek KH, Bohr DF. Whole body vascular reactivity during the development of deoxycorticosterone acetate hypertension in the pig. Circ Res 1978;42:764-771.
2. [2] Handa M, Kondo K, Suzuki H, Saruta T. Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension 1984;6:236-241.
3. [3] Grunfeld JP, Eloy L. Glucocorticoids modulate vascular reactivity in the rat. Hypertension 1987;10:608-618.
4. [4] Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992;19:567-574.
5. [5] Couture R, Regoli D. Vascular reactivity to angiotensin and noradrenaline in rats maintained on a sodium tree diet or made hypertensive with desoxycorticosterone acetate and salt. Clin Exp Hypertens 1980;2:25-43.
6. [6] Longhurst PA, Rice PJ, Taylor DA, Fleming WW. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension. Hypertension 1988;12:133-142.
7. [7] Perry PA, Webb RC. Agonist-sensitive calcium stores in arteries from steroid hypertensive rats. Hypertension 1991;17:603-611.
8. 2+ efflux in arteries from deoxycorticosterone acetate hypertensive rats. Hypertension 1992;19:734-738.
9. [9] Monney M, Schlegel PA, Brunner HR. Influence of sodium diet and deoxycorticosterone on the response to norepinephrine, lysinevasopressin and angiotensin II of isolated perfused rat mesenteric arteries. Clin Exp Hypertens Theor Prac 1983:A5:1735-1747.
10. [10] Schiffrin EL, Franks DJ, Gutkowska J. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can J Physiol Pharmacol 1985;63:1522-1527.
11. [11] Ullian ME, Schelling JR, Linas SL. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension 1992;20:67-73.
12. [12] Ullian ME, Fine JJ. Mechanisms of enhanced angiotensin II-stimulated signal transduction in vascular smooth muscle by aldosterone. J Cell Physiol 1994;161:201-208.
13. [13] Myers WJ, Nichols NR. Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta. J Steroid Biochem 1981;14:1157-1168.
14. [14] Kornel L, Ramsay C, Kanamarlapudi N, Travers T, Packer W. Evidence for the presence in arterial walls of intracellular-molecular mechanism for actin of mineralocorticoids. Clin Exper Hyper Theor Prac 1982;A4:1561-1582.
15. [15] Scott BA, Lawrence B, Nguyen HH, Meyer WJ. Aldosterone and dexamethasone binding in human arterial smooth muscle cells. J Hypertens 1987;5:739-744.
16. [16] Sato A, Suzuki H, Murakami M, Nakazato Y, Awaita Y, Saruta T. Glucocorticoid increases angiotensin II Type I receptor and its gene expression. Hypertension 1994;23:25-30.
17. [17] Schelling JR, DeLuca DJ, Konieczkowski M, et al. Glucocorticoid uncoupling of angiotensin II-dependent phospholipase C activation in rat vascular smooth muscle cells. Kidney Int 1994;46:675-682.
18. [18] Ullian ME, Hutchison FN, Hazen-Martin DJ, Morinelli TA. Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am J Physiol 1993;264:C1525-C1531.
19. [19] Ullian ME, Linas SL. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest 1989;84:840-846.
20. [20] Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
21. 1 receptors in the brain. Regul Pept 1993;44:95-107
22. [22] Todd ME, Friedman SM. The rat-tail artery maintained in culture: an experimental model. In Vitro 1978;14:757-770.
23. [23] Merrilees MJ, Scott L. Organ culture of rat carotid artery: maintenance of morphological characteristics and of pattern of matrix synthesis. In Vitro 1982;18:900-910.
24. [24] Alcantara O, Phillips JL, Bodlt DH. Phorbol diesters and transferrin modulate lymphoblastoid cell transferrin receptor expression by two different mechanisms. J Cell Physiol 1986;129:329-335.
25. [25] Mehta U, Kaul D. Effect of trifluoperazine and colchicine on smooth muscle cellular proliferative and secretory activity induced by hyper-cholesterolemic medium in vitro. Biochem Int 1990;21:107-116.
26. [26] Hofling B, Welsch U, Heimerl J, Gonschior P, Bauriedel G. Analysis of atherectomy specimens. Am J Cardiol 1993;72:96E-107E.
27. [27] Zelezna B, Richard EM, Tang W, Lu D, Sumners C, Raizada MK. Characterization of a polyclonal anti-peptide antibody to the angiotensin II type-1 receptor. Biochem Biophys Res Commun 1992;183:781-788.
28. 1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the SRC family of tyrosine kinases. Biochem Biophys Res Commun 1994;200:260-267.
29. [29] Chamley-Campbell JH, Campbell GR. What controls smooth muscle phenotype? Atherosclerosis 1981;40:347-357.
30. [30] King CM, Webb RC. The endothelium partially obscures enhanced microvessel reactivity in DOCA hypertensive rats. Hypertension 1988;12:420-427.
31. [31] Bockman CS, Jeffries WB, Pettinger WA, Abel PW. Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension. Hypertension 1992;20:304-313.
32. [32] Ronnett G.V. Knutson VP, Lane MD. Insulin-induced down-regulation of insulin receptors in 3T3-L1 adipocytes. J Biol Chem 1982;257:4285-4291.
33. [33] Wehling M, Christ M, Theisen K. High affinity aldosterone binding to plasma membrane rich fractions from mononuclear leukocytes: Is there a membrane receptor for mineralocorticoids? Biochem Biophys Res Commun 1991;181:1306-1312.
34. [34] Wehling M, Christ M, Theisen K. Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am J Physiol 1992;263:E974-E979.
35. [35] Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 1995;25:117-123.
36. 1 receptor. Am J Physiol 1993;264:F989-F995.
37. [37] Hai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW. Agonist-induced phosphorylation of the vascular type I angiotensin II receptor. Hypertension 1994;24:523-527.